Shalini Sharp - Jun 9, 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role
Director
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Shalini Sharp
Stock symbol
OGN
Transactions as of
Jun 9, 2023
Transactions value $
$200,005
Form type
4
Date filed
6/13/2023, 05:00 PM
Previous filing
May 19, 2023
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OGN Common Stock 2 Jun 9, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Phantom Stock Award $200K +10.1K +65.04% $19.83 25.6K Jun 9, 2023 Common Stock 10.1K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each phantom stock unit is an economic equivalent of one share of Organon & Co. ("Organon") common stock, or 1-for-1.
F2 Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.
F3 Holdings include phantom stock acquired in dividend reinvestment transactions on June 16, 2022, September 15, 2022, December 15, 2022 and March 16, 2023.